Skip to content
Search

Latest Stories

New NHS 'planned care' hospitals to tackle Covid-19 backlogs

NHS moves a step ahead towards its efforts to address covid-19 backlogs by opening a new 'planned care' hospital in Berkshire dedicated to non-emergency treatment. 

Heatherwood Hospital in Ascot, part of Frimley Health NHS Foundation Trust, will focus on cutting waits for routine care with staff prioritising patients who have been waiting longest, including for orthopaedic and ophthalmology services.

The hospital houses six operating theatres, 48 inpatient beds and 22 day-case cubicles and provides surgical, diagnostic and outpatient care, and will treat patients across Berkshire, Hampshire and Surrey.


There will also be a range of outpatient services under the same roof including gynaecology, urology and cardiology services. These will be supported by services offering patients endoscopy, physiotherapy, phlebotomy and radiology checks and treatments.

The elective recovery plan, published in February, set out a blueprint to address backlogs built up during the pandemic and aims to increase capacity over the next three years to deliver around 17 million diagnostic tests.

From one stop shops for lifesaving checks and new surgical hubs across the country to protect non-urgent care during the pandemic – local NHS trusts are pulling out the stops to boost capacity to carry out as many routine tests, checks and treatment as possible.

The new hospital follows other new community initiatives helping to tackle the backlog and get life-saving health checks to thousands of patients, including one stop diagnostic centres, same day hip replacements and mobile CT and MRI scanners.

Amanda Pritchard, NHS chief executive, said: “This fantastic new facility shows how the NHS is adapting and changing to meet current demands – putting in practice what we learnt about planned care during the pandemic.

“While new dedicated surgical hubs have been made available across the country to help protect non-urgent care, this hospital is the first purpose built facility aimed at tackling backlogs and getting quicker checks and treatments for patients who need routine care.”

Health secretary Sajid Javid said: “This brand-new hospital will be the first of its kind on our road to recovery and reform, putting patients in need of non-urgent care first and helping them to get the checks and treatments they need.

“We are delivering on our promise to tackle the Covid backlogs by ramping up routine surgery and providing quicker diagnoses – alongside other initiatives which include new surgical hubs and Community Diagnostic Centres, helping us to deliver 9 million more treatments, scans and operations by 2024.”

Hospitals have treated more than 600,000 patients with the virus, including over 100,000 who have been admitted so far during the Omicron wave, all while NHS staff and volunteers have continued to pull out all the stops to deliver more than 118 million vaccine doses, including more than 32 million boosters, in the biggest and most successful vaccination programme in health service history.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less